Four of the 6 proteins (67%) that decreased during EEN (ie, CCL23, IL-24, IL-6, MMP-1) were also higher in patients with CD compared with non-IBD controls prior to EEN initiation. This evidence concerns the gene IL6 and inflammatory bowel disease.